Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2044-5385
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis ; volume:12 ; number:12 ; day:19 ; month:12 ; year:2022 ; pages:1-8 ; date:12.2022
Blood cancer journal ; 12, Heft 12 (19.12.2022), 1-8, 12.2022
- Creator
-
Kwag, Daehun
Cho, Byung-Sik
Bang, Su-Yeon
Lee, Jong Hyuk
Min, Gi-June
Park, Sung-Soo
Park, Silvia
Yoon, Jae-Ho
Lee, Sung-Eun
Eom, Ki-Seong
Kim, Yoo-Jin
Lee, Seok
Min, Chang-Ki
Cho, Seok-Goo
Lee, Jong Wook
Kim, Hee-Je
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-022-00770-x
- URN
-
urn:nbn:de:101:1-2023030121014334060098
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kwag, Daehun
- Cho, Byung-Sik
- Bang, Su-Yeon
- Lee, Jong Hyuk
- Min, Gi-June
- Park, Sung-Soo
- Park, Silvia
- Yoon, Jae-Ho
- Lee, Sung-Eun
- Eom, Ki-Seong
- Kim, Yoo-Jin
- Lee, Seok
- Min, Chang-Ki
- Cho, Seok-Goo
- Lee, Jong Wook
- Kim, Hee-Je
- SpringerLink (Online service)
Other Objects (12)
The clinical value of decitabine monotherapy in patients with acute myeloid leukemia
The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia
Correction to: Decitabine/Cedazuridine: First Approval
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
Epigenetic synergy between decitabine and platinum derivatives
Immunmodulatorische Effekte von Decitabine und Azacytidine auf Natürliche Killerzellen
Expression of decitabine-targeted oncogenes in meningiomas in vivo
Expression of decitabine-targeted oncogenes in meningiomas in vivo
Epigenetic Anti‐Cancer Treatment With a Stabilized Carbocyclic Decitabine Analogue
Absence of early platelet increment in healthy mice during decitabine treatment
The clinical value of decitabine monotherapy in patients with acute myeloid leukemia
The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia
Correction to: Decitabine/Cedazuridine: First Approval
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
Epigenetic synergy between decitabine and platinum derivatives
Immunmodulatorische Effekte von Decitabine und Azacytidine auf Natürliche Killerzellen
Expression of decitabine-targeted oncogenes in meningiomas in vivo
Expression of decitabine-targeted oncogenes in meningiomas in vivo
Epigenetic Anti‐Cancer Treatment With a Stabilized Carbocyclic Decitabine Analogue
Absence of early platelet increment in healthy mice during decitabine treatment
The clinical value of decitabine monotherapy in patients with acute myeloid leukemia
The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia
Correction to: Decitabine/Cedazuridine: First Approval
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
Epigenetic synergy between decitabine and platinum derivatives
Immunmodulatorische Effekte von Decitabine und Azacytidine auf Natürliche Killerzellen
Expression of decitabine-targeted oncogenes in meningiomas in vivo
Expression of decitabine-targeted oncogenes in meningiomas in vivo
Epigenetic Anti‐Cancer Treatment With a Stabilized Carbocyclic Decitabine Analogue